Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

William Blair Downgrades Zendesk to Market Perform

William Blair analyst Arjun Bhatia downgrades Zendesk (NYSE:ZEN) from Outperform to Market Perform.
byBenzinga Newsdesk
July 26, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

William Blair analyst Arjun Bhatia downgrades Zendesk (NYSE:ZEN) from Outperform to Market Perform.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Reported Late Tuesday March 14, Jounce Therapeutics Confirms Receipt Of Unsolicited Proposal From Concentra Biosciences To Acquire 100% Of The Co. For $1.80/Share Subject To Diligence And Availability Of At Least $130M Of Cash And Equivalents At Closin…

By Happy Mohamed
March 15, 1:15 AM
The Board of Directors (the "Board") of Jounce Therapeutics, Inc. (NASDAQ:JNCE) ("Jounce" or the "Company"), a clinical-stage company focused on the discovery and development of novel cancer

JNCE